Familial deficiency of vitamin K-dependent clotting factors

Haemophilia

Volumn 14, Issue 6, 2008, Pages 1209-1213

  Weston, Brent W ^a   Monahan, P E ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

carboxylation; Haemorrhage; Polymorphisms; Reductase; Vitamin K

Indexed keywords

MENADIONE EPOXIDE; PROTHROMBIN COMPLEX; VITAMIN K DEPENDENT CARBOXYLASE; VITAMIN K GROUP;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BLEEDING TENDENCY; BRAIN HEMORRHAGE; CARBOXYLATION; CLINICAL FEATURE; DRUG MEGADOSE; FACE DYSMORPHIA; GENOTYPE; HEMARTHROSIS; HUMAN; NEONATAL HEMORRHAGE; PARTIAL THROMBOPLASTIN TIME; PATHOPHYSIOLOGY; POINT MUTATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN PROCESSING; PROTHROMBIN TIME; VITAMIN K DEFICIENCY; VITAMIN K DEPENDENT CLOTTING FACTOR DEFICIENCY; VITAMIN K DEPENDENT CLOTTING FACTOR DEFICIENCY 1; VITAMIN K DEPENDENT CLOTTING FACTOR DEFICIENCY 2; VITAMIN K METABOLISM;

ADULT; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; BLOOD PROTEINS; CARBON-CARBON LIGASES; FEMALE; HEMORRHAGE; HUMANS; INFANT; INFANT, NEWBORN; MIXED FUNCTION OXYGENASES; PLASMA; PREGNANCY; VITAMIN K;

EID: 55949134100     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01853.x     Document Type: Article

References (33)

1. McMillan CW, Roberts HR. Congenital combined deficiency of coagulation factors II, VII, IX, and X - report of a case. N Engl J Med 1966; 274: 1313-5.
2. Chung KS, Bezeaud A, Goldsmith JC, McMillan CW, Menache D, Roberts HR. Congenital deficiency of blood clotting factors II, VII, IX, and X. Blood 1979; 53: 776-87.
3. McMahon MJ, James AH. Combined deficiency of factors II, VII, IX and X (Borgschulte-Grigsby deficiency) in pregnancy. Obstet Gynecol 2001; 97: 808-9.
4. Ekelund H, Lindeberg L, Wranne L. Combined deficiency of coagulation factors II, VII, IX, and X: A case of probable congenital origin. Pediatr Hematol Oncol 1986; 3: 187-93.
5. Rost S, Geisen C, Fregin A, Seifried E, Muller CR, Oldenburg J. Founder mutation Arg485Pro led to recurrent compound heterozygous GGCX genotypes in two German patients with VCCFD type 1. Blood Coagul Fibrinolysis 2006; 17: 503-7.
6. Oldenburg J, von Brederlow B, Fregin A, et al. Congenital deficiency of vitamin K dependent coagulation factors in two families presents as a genetic defect of the vitamin K-epoxide-reductase-complex. Thromb Haemost 2000; 84: 937-41.
7. Goldsmith GH, Pence RE, Ratnoff OD, Adelstein DJ, Furie B. Studies on a family with combined functional deficiencies of vitamin K-dependent coagulation factors. J Clin Invest 1982; 69: 1253-60.
8. Darghouth D, Hallgren KW, Shtofman RL et al. Compound heterozygosity of novel missense mutations in the gamma-glutamyl carboxylase gene causes hereditary combined vitamin K-dependent coagulation factor deficiency. Blood 2006; 108: 1925-31.
9. Bhattacharyya J, Dutta P, Mishra P et al. Congenital vitamin K-dependent coagulation factor deficiency: A case report. Blood Coagul Fibrinolysis 2005; 16: 525-7.
10. Pauli RM, Lian JB, Mosher DF, Suttie JW. Association of congenital deficiency of multiple vitamin K-dependent coagulation factors and the phenotype of the warfarin embryopathy: Clues to the mechanism of teratogenicity of coumarin derivatives. Am J Hum Genet 1987; 41: 566-83.
11. Boneh A, BarZiv J. Hereditary deficiency of vitamin K-dependent coagulation factors with skeletal abnormalities. Am J Med Genet 1996; 65: 241-3.
12. Ichikawa T, Horie-Inoue K, Ikeda K, Blumberg B, Inoue S. Vitamin K2 induces phosphorylation of protein kinase A and expression of novel target genes in osteoblastic cells. J Mol Endocrinol 2007; 39: 239-47.
13. Wu SM, Morris DP, Stafford DW. Identification and purification to near homogeneity of the vitamin K-dependent carboxylase. Proc Natl Acad Sci USA 1991; 88: 2236-40.
14. Wu SM, Cheung WF, Frazier D, Stafford DW. Cloning and expression of the cDNA for human gamma-glutamyl carboxylase. Science 1991; 254: 1634-6.
15. Fregin A, Rost S, Wolz W, Krebsova A, Muller CR, Oldenburg J. Homozygosity mapping of a second gene locus for hereditary combined deficiency of vitamin K-dependent clotting factors to the centromeric region of chromosome 16. Blood 2002; 100: 3229-32.
16. Rost S, Fregin A, Ivaskevicius V et al. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature 2004; 427: 537-41.
17. Li T, Chang CY, Jin DY, Lin PJ, Khvorova A, Stafford DW. Identification of the gene for vitamin K epoxide reductase. Nature 2004; 427: 541-4.
18. Brenner B, Sanchez-Vega B, Wu SM, Lanir N, Stafford DW, Solera JA. A missense mutation in gamma-glutamyl carboxylase gene causes combined deficiency of all vitamin K-dependent blood coagulation factors. Blood 1998; 92: 4554-9.
19. Mutucumarana VP, Stafford DW, Stanley TB et al. Expression and characterization of the naturally occurring mutation L394R in human gamma-glutamyl carboxylase. J Biol Chem 2000; 275: 32572-7.
20. Wadelius M, Pirmohamed M. Pharmacogenetics of warfarin: Current status and future challenges. Pharmacogenomics J 2007; 7: 99-111.
21. Stafford DW. The vitamin K cycle. J Thromb Haemost 2005; 3: 1873-8.
22. Furie B, Furie BC. Molecular basis of vitamin K-dependent gamma-carboxylation. Blood 1990; 75: 1753-62.
23. Presnell SR, Stafford DW. The vitamin K-dependent carboxylase. Thromb Haemost 2002; 87: 937-46.
24. Zhang B, Ginsburg D. Familial multiple coagulation factor deficiencies: new biologic insight from rare genetic bleeding disorders. J Thromb Haemost 2004; 2: 1564-72.
25. Sadler JE. Medicine: K is for koagulation. Nature 2004; 427: 493-4.
26. Thomas A, Stirling D. Four factor deficiency. Blood Coagul Fibrinolysis 2003; 14 (suppl.1): S55-7.
27. Marchetti G, Caruso P, Lunghi B, et al. Vitamin K-induced modification of coagulation phenotype in VKORC1 homozygous deficiency. J Thromb Haemost 2008; 6: 797-803.
28. Brenner B, Tavori S, Zivelin A, et al. Hereditary deficiency of all vitamin K-dependent procoagulants and anticoagulants. Br J Haematol 1990; 75: 537-42.
29. Hauschka PV, Lian JB, Cole DEC, Gundberg CM. Osteocalcin and matrix Gla protein-vitamin K dependent proteins in bone. Physiol Rev 1989; 69: 990-1047.
30. Mutucumarana VP, Archer F, Straight DL, Jin DY, Stafford DW. A conserved region of human vitamin K-dependent carboxylase between residues 393 and 404 is important for its interaction with the glutamate substrate. J Biol Chem 2003; 278: 46488-93.
31. Soute BAM, Jin DY, Spronk MH et al. Characteristics of recombinant W501S mutated human gamma-glutamyl carboxylase. J Thromb Haemost 2004; 2: 597-604.
32. Jin DY, Tie JK, Stafford DW. The conversion of vitamin K quinone and vitamin K quinone to vitamin k hydroquinone uses the same active site cysteines. Biochemistry 2007; 46: 7279-83.
33. Leissinger CA, Blatt PM, Hoots WK, Ewenstein B. Role of prothrombin complex concentrates in reversing warfarin anticoagulation: A review of the literature. Am J Hematol 2008; 83: 137-43.